305 related articles for article (PubMed ID: 23115008)
21. O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner.
Gomez Toledo A; Raducu M; Cruces J; Nilsson J; Halim A; Larson G; Rüetschi U; Grahn A
Glycobiology; 2012 Nov; 22(11):1413-23. PubMed ID: 22781125
[TBL] [Abstract][Full Text] [Related]
22. Glycobiology of α-dystroglycan and muscular dystrophy.
Endo T
J Biochem; 2015 Jan; 157(1):1-12. PubMed ID: 25381372
[TBL] [Abstract][Full Text] [Related]
23. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding.
Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP
Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576
[TBL] [Abstract][Full Text] [Related]
24. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain.
Breloy I; Schwientek T; Gries B; Razawi H; Macht M; Albers C; Hanisch FG
J Biol Chem; 2008 Jul; 283(27):18832-40. PubMed ID: 18456664
[TBL] [Abstract][Full Text] [Related]
25. Dystroglycan glycosylation and muscular dystrophy.
Moore CJ; Hewitt JE
Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291
[TBL] [Abstract][Full Text] [Related]
26. Carbohydrate-binding domain of the POMGnT1 stem region modulates O-mannosylation sites of α-dystroglycan.
Kuwabara N; Manya H; Yamada T; Tateno H; Kanagawa M; Kobayashi K; Akasaka-Manya K; Hirose Y; Mizuno M; Ikeguchi M; Toda T; Hirabayashi J; Senda T; Endo T; Kato R
Proc Natl Acad Sci U S A; 2016 Aug; 113(33):9280-5. PubMed ID: 27493216
[TBL] [Abstract][Full Text] [Related]
27. Absence of post-phosphoryl modification in dystroglycanopathy mouse models and wild-type tissues expressing non-laminin binding form of α-dystroglycan.
Kuga A; Kanagawa M; Sudo A; Chan YM; Tajiri M; Manya H; Kikkawa Y; Nomizu M; Kobayashi K; Endo T; Lu QL; Wada Y; Toda T
J Biol Chem; 2012 Mar; 287(12):9560-7. PubMed ID: 22270369
[TBL] [Abstract][Full Text] [Related]
28. Like-acetylglucosaminyltransferase (LARGE)-dependent modification of dystroglycan at Thr-317/319 is required for laminin binding and arenavirus infection.
Hara Y; Kanagawa M; Kunz S; Yoshida-Moriguchi T; Satz JS; Kobayashi YM; Zhu Z; Burden SJ; Oldstone MB; Campbell KP
Proc Natl Acad Sci U S A; 2011 Oct; 108(42):17426-31. PubMed ID: 21987822
[TBL] [Abstract][Full Text] [Related]
29. Glycosylation defects in muscular dystrophies.
Haliloğlu G; Topaloğlu H
Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
[TBL] [Abstract][Full Text] [Related]
30. Differential glycosylation of α-dystroglycan and proteins other than α-dystroglycan by like-glycosyltransferase.
Zhang P; Hu H
Glycobiology; 2012 Feb; 22(2):235-47. PubMed ID: 21930648
[TBL] [Abstract][Full Text] [Related]
31. Protein
Halmo SM; Singh D; Patel S; Wang S; Edlin M; Boons GJ; Moremen KW; Live D; Wells L
J Biol Chem; 2017 Feb; 292(6):2101-2109. PubMed ID: 27932460
[TBL] [Abstract][Full Text] [Related]
32. Disease mutations in CMP-sialic acid transporter SLC35A1 result in abnormal α-dystroglycan O-mannosylation, independent from sialic acid.
Riemersma M; Sandrock J; Boltje TJ; Büll C; Heise T; Ashikov A; Adema GJ; van Bokhoven H; Lefeber DJ
Hum Mol Genet; 2015 Apr; 24(8):2241-6. PubMed ID: 25552652
[TBL] [Abstract][Full Text] [Related]
33. Glycomarkers for muscular dystrophy.
Hewitt JE
Biochem Soc Trans; 2011 Jan; 39(1):336-9. PubMed ID: 21265799
[TBL] [Abstract][Full Text] [Related]
34. CDP-glycerol inhibits the synthesis of the functional
Imae R; Manya H; Tsumoto H; Osumi K; Tanaka T; Mizuno M; Kanagawa M; Kobayashi K; Toda T; Endo T
J Biol Chem; 2018 Aug; 293(31):12186-12198. PubMed ID: 29884773
[TBL] [Abstract][Full Text] [Related]
35. N-terminal domain on dystroglycan enables LARGE1 to extend matriglycan on α-dystroglycan and prevents muscular dystrophy.
Okuma H; Hord JM; Chandel I; Venzke D; Anderson ME; Walimbe AS; Joseph S; Gastel Z; Hara Y; Saito F; Matsumura K; Campbell KP
Elife; 2023 Feb; 12():. PubMed ID: 36723429
[TBL] [Abstract][Full Text] [Related]
36. Crystal structures of β-1,4-N-acetylglucosaminyltransferase 2: structural basis for inherited muscular dystrophies.
Yang JY; Halmo SM; Praissman J; Chapla D; Singh D; Wells L; Moremen KW; Lanzilotta WN
Acta Crystallogr D Struct Biol; 2021 Apr; 77(Pt 4):486-495. PubMed ID: 33825709
[TBL] [Abstract][Full Text] [Related]
37. The functional O-mannose glycan on α-dystroglycan contains a phospho-ribitol primed for matriglycan addition.
Praissman JL; Willer T; Sheikh MO; Toi A; Chitayat D; Lin YY; Lee H; Stalnaker SH; Wang S; Prabhakar PK; Nelson SF; Stemple DL; Moore SA; Moremen KW; Campbell KP; Wells L
Elife; 2016 Apr; 5():. PubMed ID: 27130732
[TBL] [Abstract][Full Text] [Related]
38. Old World and clade C New World arenaviruses mimic the molecular mechanism of receptor recognition used by alpha-dystroglycan's host-derived ligands.
Rojek JM; Spiropoulou CF; Campbell KP; Kunz S
J Virol; 2007 Jun; 81(11):5685-95. PubMed ID: 17360738
[TBL] [Abstract][Full Text] [Related]
39. Conditional knockout of protein O-mannosyltransferase 2 reveals tissue-specific roles of O-mannosyl glycosylation in brain development.
Hu H; Li J; Gagen CS; Gray NW; Zhang Z; Qi Y; Zhang P
J Comp Neurol; 2011 May; 519(7):1320-37. PubMed ID: 21452199
[TBL] [Abstract][Full Text] [Related]
40. Mammalian
Larsen ISB; Narimatsu Y; Joshi HJ; Yang Z; Harrison OJ; Brasch J; Shapiro L; Honig B; Vakhrushev SY; Clausen H; Halim A
J Biol Chem; 2017 Jul; 292(27):11586-11598. PubMed ID: 28512129
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
